Andrew Douglas
Andrew brings over 20 years of experience leading data science, technology and strategy teams. Most recently, Andrew helped propel RELX through data and digital transformation in a global capacity, leading data platform, analytics and data science as Vice President, Data and Data Science — Research Products. Previously, Andrew served as IBM Corporate Vice President of Data Platforms and Data Strategy. There, he was responsible for building a best-in-class big data platform connecting consumer touch-points, from impression to revenue. In addition, he also led teams in the implementation of the MarTech/AdTech stack and created AI capabilities around multitouch attribution, content and audience targeting and visibility to performance.
Prior to joining IBM, Andrew was GVP of Marketing Science at WebMD, where he created their research and data analytics platforms, driving digital promotion targeting and strategy, editorial content delivery, client insight, and value measurement. Andrew also led the development and commercialization of predictive models of seasonal epidemiological events (e.g., cold and flu, allergy, flea and ticks, STDs) that are currently being used for programmatic media buying and bio-surveillance tracking. Earlier, Andrew led a consultancy team of advanced analytics experts and statisticians as SVP of Marketing Science at GFK, was a principal data scientist at Unilever, and, early in his career, was lead statistician for a small biotech company, PsychoGenics, on the forefront of utilizing Bayesian statistics for novel compound discovery.
Andrew has a BS in Biological Psychology from Colorado State University, as well as an MS and a completed PhD work in Behavioral Neuroscience at Binghamton University.
